Formulation development

Formulation development
Product Description

Conscio provides comprehensive formulation development services, from early feasibility and proof-of-concept studies to advanced formulation design, process optimisation, and upscaling for clinical supply. We support a broad range of projects, including new chemical entities (NCE), new therapeutic entities (NTE), generics (Gx), and over-the-counter (OTC) products.
Capabilities include the development of a broad spectrum of dosage forms, covering solid, liquid, semi-solid, and specialised delivery systems. Each form is designed with consideration for patient needs, therapeutic goals, manufacturing feasibility, and regulatory compliance.

Conscio Group

  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
Academic/Research
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Distributor/Import Export
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Clinical Research
Contract Research Organisation
Laboratory Services
Specifications

Conscio Group

  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
Academic/Research
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Distributor/Import Export
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Clinical Research
Contract Research Organisation
Laboratory Services

More Products from Conscio Group (6)

  • Clinical trials

    Product Clinical trials

    Conscio offers a comprehensive portfolio of early-phase clinical trial services, underpinned by decades of expertise and integrated departmental cooperation. Our two fully equipped clinical units in the Czech Republic have a combined capacity of 96 beds and deliver high-quality, regulatory-compliant studie...
  • Bioanalytical testing

    Product Bioanalytical testing

    We provide analytical services from pre-clinical studies through Phase III, including full statistical evaluation. Our experienced team has successfully completed more than 780 biostudies for pharmaceutical companies across Europe, the United States, Asia, and Australia.

    The Bioanalytical de...
  • Quality control: Pharmaceuticals

    Product Quality control: Pharmaceuticals

    The Pharmaceutical Analyses Department provides precise and reliable testing to support pharmaceutical development, manufacturing, and quality control. All activities are performed under Good Manufacturing Practice (GMP) and in accordance with current ICH guidelines. Using advanced analytical methods and m...
  • Quality Control: Biologics and Biosimilars

    Product Quality Control: Biologics and Biosimilars

    The Biopharmaceutical Analyses Department provides comprehensive analytical services to support the development, characterisation, and quality control of biologics and biosimilars. Our expertise covers a wide spectrum of molecules, including peptides, monoclonal antibodies, fusion proteins, and antibody–dr...
  • IMP Manufacturing

    Product IMP Manufacturing

    GMP-compliant manufacturing of investigational medicinal products (IMPs) is carried out in a fully equipped 1,340 m² facility designed for small-scale production to meet clinical trial needs, including Phase I, Phase II, pilot, and bioequivalence (BE) studies. Services cover the full process from developme...
  • Analytical R&D

    Product Analytical R&D


    Analytical R&D at Conscio supports pharmaceutical development and registration with services including analytical method development, impurity identification, degradation and stability studies, trace analyses, nitrosamines testing, extractables and leachables studies, IVRT/IVPT method developme...